Jun 6, 2023 08:30AM
Jul 20, 2022 08:30AM
Jan 14, 2022 12:15PM
Nov 23, 2021 07:00AM
May 12, 2021 08:00AM
Apr 22, 2021 08:00AM
Apr 14, 2021 08:00AM ProtoKinetix Engages Multi-National Partner for Formulation of Topical Drug to Treat Dry Eye Disease & Ocular Inflammation with AAGP®
Sep 15, 2020 09:00AM
Aug 27, 2020 09:00AM
Aug 14, 2020 09:00AM
Jul 13, 2020 08:30AM
Jul 7, 2020 08:30AM
Apr 6, 2020 08:30AM
Mar 24, 2020 08:30AM ProtoKinetix Ready to Ship AAGP® to the University of Alberta for the Continuation of Phase 1 Human Trials
Mar 19, 2020 09:00AM
Feb 19, 2020 09:00AM
Feb 11, 2020 08:00AM
Jan 24, 2020 08:30AM
Jan 6, 2020 08:30AM
Dec 19, 2019 08:30AM
Nov 22, 2019 09:00AM ProtoKinetix AAGP® Dry Eye Therapy Program Launched
Nov 6, 2019 09:00AM
Aug 23, 2019 09:00AM
Jul 9, 2019 09:00AM
Jun 7, 2019 09:00AM
May 30, 2019 03:45PM
May 9, 2019 09:15AM
May 6, 2019 06:00PM ProtoKinetix Discusses Investor Awareness Campaign and Recent Market Activity
Apr 23, 2019 09:15AM
Feb 26, 2019 09:24AM
Jan 16, 2019 09:15AM
Dec 19, 2018 09:15AM
Sep 28, 2018 09:15AM
Sep 4, 2018 09:00AM
Aug 10, 2018 03:55PM ProtoKinetix Enters into 3rd Phase of Retinal Cell Replacement Therapy Testing at UBC
Jun 13, 2018 09:15AM
Jan 10, 2018 09:15AM
Nov 16, 2017 12:17PM
Oct 17, 2017 09:15AM
Jun 5, 2017 10:37AM
May 24, 2017 09:30AM
Mar 9, 2017 09:15AM ProtoKinetix Announces Start of Phase 1 & Phase 2 Clinical Trials for the use of AAGP™ PKX-001 Treated Islet Cells in the Treatment of Type 1 Diabetes
Feb 7, 2017 01:22PM
Jan 24, 2017 09:15AM
Jan 17, 2017 09:15AM
Jul 14, 2016 09:30AM
Jun 16, 2016 03:31PM
Jun 7, 2016 11:00AM
May 12, 2016 10:00AM ProtoKinetix Updates Progress Toward Clinical Trial Application for AAGP™
May 2, 2016 10:41AM

1,161,403 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All